Your Article Summary
See Latest ArticlesThiazolidinediones and vascular damage
Current Opinion in Endocrinology, Diabetes and Obesity, 03/05/07
Goldberg, Ronald B, - Will use of these drugs prevent cardiovascular disease?
>Summary: The purpose of this review was to investigate the possibility of thiazolidinedione agents having vasculoprotective effects and if so whether these are associated with the prevention of cardiovascular disease.
Outcomes: The weight of the experimental, subclinical and clinical assessments of the effects of these agents supports the contention that they are vasculoprotective. In the final analysis their use in clinical practice to prevent cardiovascular disease will mostly depend on whether clinical trials consistently demonstrate that they reduced cardiovascular events
Related Articles
Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 87%
Combination of nateglinide with thiazolidinediones in Type 2 diabetes
Expert Review of Endocrinology & Metabolism, 11/10/09
Relevance Score: 84%
Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone
Journal of Clinical Endocrinology and Metabolism, 11/10/09
Relevance Score: 84%
Pioglitazone Increases the Proportion of Small Cells in Human Abdominal Subcutaneous Adipose Tissue
Obesity, 11/17/09
Relevance Score: 80%
Fractures Associated With Diabetes
Ivanhoe, 10/02/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/14/09
Thiazolidinediones and the liver in humans
Current Opinion in Lipidology, 12/14/09
Effect of Obesity on Platelet Reactivity and Response to Low-Dose Aspirin
Preventive Cardiology, 12/14/09
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnosis, management and therapeutic outcome in prepubertal Cushing’s disease
European Journal of Endocrinology, 12/14/09
Circulating vaspin is unrelated to insulin sensitivity in a cohort of non-diabetic humans
European Journal of Endocrinology, 12/14/09
Thiazolidinediones and the liver in humans
Current Opinion in Lipidology, 12/14/09
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
The role of flow-mediated dilatation in the evaluation and development of antiatherosclerotic drugs
Current Opinion in Lipidology, 12/14/09
Travel-related thromboembolism: mechanisms and avoidance
Expert Review of Cardiovascular Therapy , 12/14/09
High-throughput ambulatory assessment of digital reactive hyperemia: Concurrent validity with known cardiovascular risk factors and potential confounding
Preventive Medicine, 12/14/09